Want to join the conversation?
$EXPE's total cost of revenue rose 11% YoverY to $1.31Bil in 2015. The rise in cost was driven by $61MM of higher data center and other costs as well as $37MM of higher net credit card processing costs related to growth of $EXPE's merchant bookings. Additionally, customer operation expenses rose $33MM to support volume growth across the company.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?